Microbiome Diagnostics Market by Product Type, Application, End-user - Global Forecast 2025-2030- Product Image

Sale

Microbiome Diagnostics Market by Product Type, Application, End-user - Global Forecast 2025-2030

Report
197 Pages
October 2024
Region: Global
360iResearch™
ID: 5968243

UP TO €681EUR$697USD£569GBP OFF until Dec 31^st 2024

The Microbiome Diagnostics Market grew from USD 799.36 million in 2023 to USD 960.27 million in 2024. It is expected to continue growing at a CAGR of 20.72%, reaching USD 2.98 billion by 2030.

Microbiome diagnostics refers to the analysis and study of microbial communities in various environments, including the human body, to understand their roles and impact on health and disease. The necessity of microbiome diagnostics is underscored by its potential to revolutionize personalized medicine, offering insights into disease predisposition, treatment responses, and preventive healthcare strategies. Applications span from gastrointestinal disorders, metabolic diseases, and oncology to personalized nutrition and antibiotic stewardship. The end-use scope primarily includes hospitals, diagnostic laboratories, research institutions, and pharmaceutical companies. Key growth drivers include advancements in sequencing technologies, increasing prevalence of lifestyle-related diseases, and growing awareness of the microbiome's role in health. Opportunities lie in leveraging machine learning for data analysis, expanding applications in therapeutics and agriculture, and integrating microbiome diagnostics into routine healthcare. To seize these opportunities, companies should focus on partnerships with research institutions, investment in AI-enabled platforms, and exploring unmet needs in non-invasive testing modalities. Challenges impacting growth consist of ethical and regulatory concerns, complexities related to data interpretation, and the high cost of advanced sequencing technologies. Limiting factors also include a lack of standardized methodologies and insufficient awareness among clinicians and patients. Innovation should be directed towards developing cost-effective, rapid, and comprehensive diagnostic solutions, as well as enhancing the accuracy and ease of data interpretation. This can be achieved by focusing on multi-omics approaches and creating user-friendly analytic software. The microbiome diagnostics market is dynamic, characterized by rapid technological developments and increasing competition. Businesses can thrive by maintaining a keen focus on regulatory compliance and fostering collaborative ecosystems to expedite research and commercialization. Emphasizing educational initiatives for stakeholders will also be critical in easing adoption and widening the market reach.

Understanding Market Dynamics in the Microbiome Diagnostics Market

The Microbiome Diagnostics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Rising prevalence of chronic diseases and significance of microbiome-based diagnostics
- Government initiatives and support for microbiome research
Market Restraints
- Lack of reimbursement policies for microbiome-based diagnostics
Market Opportunities
- Increasing investment in microbiome-based research
- Growing potential of microbiome diagnostics in developing personalized treatments
Market Challenges
- Lack of standardized protocols and available therapeutics targeting the microbiome

Exploring Porter’s Five Forces for the Microbiome Diagnostics Market

Porter’s Five Forces framework further strengthens the insights of the Microbiome Diagnostics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Microbiome Diagnostics Market

External macro-environmental factors deeply influence the performance of the Microbiome Diagnostics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Microbiome Diagnostics Market

The Microbiome Diagnostics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Microbiome Diagnostics Market

The Microbiome Diagnostics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Microbiome Diagnostics Market

The Microbiome Diagnostics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Microbiome Diagnostics Market, highlighting leading vendors and their innovative profiles. These include 4D Pharma PLC, AOBiome Therapeutics, Atlas Biomed, BioGaia, BIOHM Health, Bione Ventures Private Limited, DayTwo, DNA Genotek Inc. by OraSure Technologies Inc., Du Pont De Nemours and Co., Enterome, Evvy, Ferring Pharmaceuticals, Finch Therapeutics Group, Flightpath Biosciences, Inc., Genetic Analysis AS, Gnubiotics Sciences, International Flavors & Fragrances Inc, Luxia Scientific, MEtabiomics, Microba Life Sciences, OptiBiotix Health PLC, Osel Inc., Quantbiome, Inc., Rebiotix, Second Genome, Inc., Seed Health, Seres Therapeutics, Sun Genomics, Symbiotix Biotherapies,, Synlogic, Inc., Synthetic Biologics, Vedanta Biosciences, Inc., Viome Life Sciences, Inc., ViThera, ViThera Pharmaceuticals, Inc., Yakult Honsha Co., and YSOPIA Bioscience.

Market Segmentation & Coverage

This research report categorizes the Microbiome Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
- Instruments
- Reagents & Kits
Application
- Gastrointestinal Disorders
- Infectious Diseases
- Metabolic Disorders
End-user
- Pharmaceutical & Biotechnology Companies
- Research & Academic Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of chronic diseases and significance of microbiome-based diagnostics
5.1.1.2. Government initiatives and support for microbiome research
5.1.2. Restraints
5.1.2.1. Lack of reimbursement policies for microbiome-based diagnostics
5.1.3. Opportunities
5.1.3.1. Increasing investment in microbiome-based research
5.1.3.2. Growing potential of microbiome diagnostics in developing personalized treatments
5.1.4. Challenges
5.1.4.1. Lack of standardized protocols and available therapeutics targeting the microbiome
5.2. Market Segmentation Analysis
5.2.1. Product Type: Need for accurate and efficient instruments capable of handling complex analyses
5.2.2. End-user: Growing adoption of microbiome diagnostics in pharmaceutical and biotechnology companies to develop personalized therapies
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Microbiome Diagnostics Market, by Product Type

6.1. Introduction
6.2. Instruments
6.3. Reagents & Kits

7. Microbiome Diagnostics Market, by Application

7.1. Introduction
7.2. Gastrointestinal Disorders
7.3. Infectious Diseases
7.4. Metabolic Disorders

8. Microbiome Diagnostics Market, by End-user

8.1. Introduction
8.2. Pharmaceutical & Biotechnology Companies
8.3. Research & Academic Institutes

9. Americas Microbiome Diagnostics Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Microbiome Diagnostics Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Microbiome Diagnostics Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Launch of “Targeted Microbiome Profiling”, a pathway-based microbiome profiling service for health and disease
12.3.2. Evvy, Precision Women’s Health Startup focused on the Vaginal Microbiome, Announces USD 14 million Series A
12.3.3. Xume partners with Microbiome.in and TruDiagno to help people make gut microbiome-informed choices
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio

List of Figures

FIGURE 1. MICROBIOME DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. MICROBIOME DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MICROBIOME DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. MICROBIOME DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. MICROBIOME DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. MICROBIOME DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 28. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 29. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 30. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 35. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 36. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 37. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 38. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 41. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 42. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 43. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 44. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 47. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 48. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 49. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 52. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 53. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 54. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 55. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 58. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 59. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 60. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 61. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 68. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 75. AUSTRALIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 76. AUSTRALIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 77. AUSTRALIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 78. AUSTRALIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 81. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 82. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 83. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 86. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 87. INDIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 88. INDIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 89. INDIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. INDIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. INDIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. INDIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. INDONESIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 94. INDONESIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 95. INDONESIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. INDONESIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 99. JAPAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 100. JAPAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 101. JAPAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. JAPAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. JAPAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 104. JAPAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 105. MALAYSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 106. MALAYSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 107. MALAYSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. MALAYSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 111. PHILIPPINES MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 112. PHILIPPINES MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 113. PHILIPPINES MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. PHILIPPINES MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 117. SINGAPORE MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 118. SINGAPORE MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 119. SINGAPORE MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. SINGAPORE MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 123. SOUTH KOREA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 124. SOUTH KOREA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 125. SOUTH KOREA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. SOUTH KOREA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 129. TAIWAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 130. TAIWAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 131. TAIWAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. TAIWAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 135. THAILAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 136. THAILAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 137. THAILAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. THAILAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. THAILAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 140. THAILAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 141. VIETNAM MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 142. VIETNAM MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 143. VIETNAM MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. VIETNAM MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 155. DENMARK MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 156. DENMARK MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 157. DENMARK MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 158. DENMARK MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 159. DENMARK MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 160. DENMARK MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 161. EGYPT MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 162. EGYPT MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 163. EGYPT MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. EGYPT MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. EGYPT MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. EGYPT MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. FINLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 168. FINLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 169. FINLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. FINLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. FINLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 172. FINLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 173. FRANCE MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 174. FRANCE MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 175. FRANCE MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. FRANCE MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. FRANCE MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 178. FRANCE MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 179. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 180. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 181. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 182. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 183. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 184. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 185. ISRAEL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 186. ISRAEL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 187. ISRAEL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. ISRAEL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 191. ITALY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 192. ITALY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 193. ITALY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. ITALY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. ITALY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 196. ITALY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 197. NETHERLANDS MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 198. NETHERLANDS MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 199. NETHERLANDS MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. NETHERLANDS MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 203. NIGERIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 204. NIGERIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 205. NIGERIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 206. NIGERIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 209. NORWAY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 210. NORWAY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 211. NORWAY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. NORWAY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. NORWAY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 214. NORWAY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 215. POLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 216. POLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 217. POLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. POLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. POLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 220. POLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 221. QATAR MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 222. QATAR MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 223. QATAR MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. QATAR MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. QATAR MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 226. QATAR MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 227. RUSSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 228. RUSSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 229. RUSSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. RUSSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 234. SAUDI ARABIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. SAUDI ARABIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 240. SOUTH AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. SOUTH AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 245. SPAIN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 246. SPAIN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 247. SPAIN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. SPAIN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. SPAIN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 250. SPAIN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 251. SWEDEN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 252. SWEDEN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 253. SWEDEN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. SWEDEN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 257. SWITZERLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 258. SWITZERLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 259. SWITZERLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. SWITZERLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 263. TURKEY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 264. TURKEY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 265. TURKEY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. TURKEY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. TURKEY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 268. TURKEY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 276. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 281. MICROBIOME DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 282. MICROBIOME DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Microbiome Diagnostics market, which are profiled in this report, include:

4D Pharma PLC
AOBiome Therapeutics
Atlas Biomed
BioGaia
BIOHM Health
Bione Ventures Private Limited
DayTwo
DNA Genotek Inc. by OraSure Technologies Inc.
Du Pont De Nemours and Co.
Enterome
Evvy
Ferring Pharmaceuticals
Finch Therapeutics Group
Flightpath Biosciences, Inc.
Genetic Analysis AS
Gnubiotics Sciences
International Flavors & Fragrances Inc
Luxia Scientific
MEtabiomics
Microba Life Sciences
OptiBiotix Health PLC
Osel Inc.
Quantbiome, Inc.
Rebiotix
Second Genome, Inc.
Seed Health
Seres Therapeutics
Sun Genomics
Symbiotix Biotherapies,
Synlogic, Inc.
Synthetic Biologics
Vedanta Biosciences, Inc.
Viome Life Sciences, Inc.
ViThera
ViThera Pharmaceuticals, Inc.
Yakult Honsha Co.
YSOPIA Bioscience

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	197
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 960.27 Million
Forecasted Market Value ( USD ) by 2030	$ 2980 Million
Compound Annual Growth Rate	20.7%
Regions Covered	Global
No. of Companies Mentioned	37

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3466EUR$3,545USD£2,895GBP €3851EUR$3,939USD£3,217GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6132EUR$6,272USD£5,122GBP €6813EUR$6,969USD£5,691GBP

Understanding Market Dynamics in the Microbiome Diagnostics Market

Exploring Porter’s Five Forces for the Microbiome Diagnostics Market

Applying PESTLE Analysis to the Microbiome Diagnostics Market

Analyzing Market Share in the Microbiome Diagnostics Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Microbiome Diagnostics Market

Strategic Recommendations for Success in the Microbiome Diagnostics Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Cancer Microbiome Sequencing Market by Product, Technology, Application, End User - Global Forecast 2025-2030

Human Microbiome Market by Disease, Technology, Product, Therapeutic Area, Application - Global Forecast 2025-2030

Microbiome Diagnostics Market by Product (Kits & Reagents, Instruments), Technology (16s rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics), Sample (Fecal, Saliva, Skin), Application (GI, Metabolic Disorders) - Forecast to 2028

Microbiome Sample Preparation Technology Market Size, Share & Trends Analysis Report by Product (Instruments, Consumables), Workflow, Application, Disease, End-use, Region, and Segment Forecasts, 2025-2030

Microbiome Diagnostics Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)